Page last updated: 2024-11-05

n-acetylpenicillamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

N-acetylpenicillamine: RN given refers to (DL)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N-acetyl-D-penicillamine : An N-acetyl-D-amino acid where the amino acid is D-penicillamine [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID65532
CHEBI ID61198
SCHEMBL ID4468919
MeSH IDM0055215

Synonyms (31)

Synonym
n-acetylpenicillamine
n-acetyl-3-mercaptovaline
(2s)-2-acetamido-3-methyl-3-sulfanylbutanoic acid
n-acetyl-3-mercapto-d-valine
15537-71-0
n-acetyl-2-amino-3-mercapto-3-methylbutansaeure
n-acetyl-d-penicillamine
n-acetyl-3-sulfanyl-d-valine
CHEBI:61198 ,
d-valine, n-acetyl-3-mercapto-
unii-wo11m5k6or
einecs 239-585-4
wo11m5k6or ,
n-acetyl-3-dimethyl-dl-cysteine
EPITOPE ID:140792
AKOS015894387
n-acetylpenicillamine d-form
n-acetylpenicillamine, d-
n-acetylpenicillamine d-form [mi]
SCHEMBL4468919
n-acetyl-3-mercapto-d-valin
MNNBCKASUFBXCO-YFKPBYRVSA-N
n-acetyl-d-penicillamine, for hplc derivatization, >=99.0% (t)
AS-60162
J-009191
(s)-2-acetamido-3-mercapto-3-methylbutanoic acid
d-n-acetylpenicillamine
Q27130879
AMY22209
EN300-59095
DTXSID701030813

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The decision to complete the therapeutic regimen despite an adverse reaction was justified by the striking clinical improvement."( Successful treatment of inorganic mercury neurotoxicity with N-acetyl-penicillamine despite an adverse reaction.
Markowitz, L; Schaumburg, HH, 1980
)
0.26
"Inclusion of sodium nitroprusside (Na2[Fe(2+)-(CN)5NO]) into the culture medium is toxic to cultured rat cerebellar granule neurons."( Inhibition of excitatory amino acid-induced phosphoinositide hydrolysis as a possible mechanism of nitroprusside neurotoxicity.
Chuang, DM; Yu, O, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
N-acetyl-D-amino acidAn N-acetyl-amino acid having D-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (38.30)18.7374
1990's18 (38.30)18.2507
2000's6 (12.77)29.6817
2010's5 (10.64)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.08%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (6.25%)4.05%
Observational0 (0.00%)0.25%
Other44 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]